Olubuyide I O, Festing M F, Chapman C, Higginson J, Whicher J T
MRC Toxicology Unit, University of Leicester, UK.
Trop Gastroenterol. 1997 Jan-Mar;18(1):15-9.
Discriminant function analysis has been used to investigate the relative value of six biochemical parameters (plasma ferritin, C-reactive-protein, bilirubin, alkaline phosphatase, glutamic oxaloacetic acid transaminase and albumin) in the diagnosis of liver disease. This was done among four groups totalling 70 subjects including healthy controls and patients with acute viral hepatitis, liver cirrhosis and primary hepatocellular carcinoma. Albumin had most value in distinguishing between groups, followed cumulatively by ferritin, alkaline phosphatase, C-reactive protein, bilirubin and glutamic oxaloacetic acid transaminase. However, if data on albumin, alkaline phosphatase, bilirubin and glutamic oxaloacetic acid transaminase had already been routinely collected, there would be no advantage in collecting data on ferritin and C-reactive protein. Any four of the six parameters would be of about equal value in distinguishing between diagnostic groups. When the data on all six biochemical parameters was combined in an optimum way, about 66% of all individuals could be correctly assigned to one of the four groups using biochemical markers alone. While the control subjects and patients with acute viral hepatitis formed a relatively well defined, tight cluster (apart from two patients with acute viral hepatitis), patients with liver cirrhosis and primary hepatocellular carcinoma were almost indistinguishable, using these biochemical parameters. If the latter two groups were pooled, then about 86% of subjects could be correctly classified.
判别函数分析已被用于研究六种生化参数(血浆铁蛋白、C反应蛋白、胆红素、碱性磷酸酶、谷草转氨酶和白蛋白)在肝病诊断中的相对价值。研究对象共70名,分属四组,包括健康对照者以及急性病毒性肝炎、肝硬化和原发性肝细胞癌患者。白蛋白在区分不同组时价值最大,其次依次为铁蛋白、碱性磷酸酶、C反应蛋白、胆红素和谷草转氨酶。然而,如果已经常规收集了白蛋白、碱性磷酸酶、胆红素和谷草转氨酶的数据,那么再收集铁蛋白和C反应蛋白的数据就没有优势。六个参数中的任意四个在区分诊断组时价值大致相当。当以最佳方式合并所有六个生化参数的数据时,仅使用生化标志物就能将约66%的个体正确归为四组之一。虽然健康对照者和急性病毒性肝炎患者形成了一个相对明确、紧密的聚类(除两名急性病毒性肝炎患者外),但使用这些生化参数时,肝硬化患者和原发性肝细胞癌患者几乎无法区分。如果将后两组合并,那么约86%的受试者能够被正确分类。